Monday - November 16, 2026
PLCg2 and phospholipase A1 pathways may converge to reduce the risk of Alzheimer's disease
September 21, 2026
KUOPIO, Finland, Sept. 21 -- The University of Eastern Finland posted the following news:

* * *

PLCg2 and phospholipase A1 pathways may converge to reduce the risk of Alzheimer's disease

*

Two studies involving researchers at the University of Eastern Finland highlight a central role for the PLCg2 signalling pathway in Alzheimer's disease. Protective PLCG2 variants, encoding the signalling enzyme PLCg2, were found to delay disease ons . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products